Document Detail

Acute Versus Chronic Exposure to Androgen Suppression for Prostate Cancer: Impact on the Exercise Response.
MedLine Citation:
PMID:  21849187     Owner:  NLM     Status:  Publisher    
PURPOSE: Exercise has been proposed as an effective countermeasure for androgen suppression therapy induced side effects. Since the magnitude of fat gain and muscle loss is most pronounced during the early phases of androgen suppression therapy, the exercise response may differ by the duration of androgen suppression therapy. We investigated whether the exercise response varied by the prior duration of exposure to androgen suppression therapy, that is acute-less than 6 months vs later-6 months or greater. MATERIALS AND METHODS: A total of 50 men 55 to 84 years old undergoing androgen suppression therapy for nonbone metastatic prostate cancer completed a progressive resistance and cardiovascular exercise program for 12 weeks, including 16 with acute and 34 with chronic androgen suppression therapy exposure. We assessed fat and lean mass by dual energy x-ray absorptiometry as well as muscle strength, functional performance, quality of life and blood biomarkers. RESULTS: Patients on acute androgen suppression showed an increase in total body fat compared to those on chronic androgen suppression (0.9 kg, p = 0.018). Each group experienced increased appendicular skeletal muscle (about 0.5 kg, p <0.01). Triglycerides decreased in the chronic group and increased in the acute group (p = 0.027). Change in triglycerides were associated with the change in total body fat (r = 0.411, p = 0.004). There were no differences between the groups in prostate specific antigen, testosterone, glucose, insulin, total cholesterol, low and high density lipoprotein, cholesterol, C-reactive protein, homocysteine or quality of life. The 2 groups showed similar improvement in muscle strength and function, and cardiovascular fitness. CONCLUSIONS: Apart from differences in body fat and triglycerides the beneficial effects of exercise are similar in patients on acute or chronic androgen suppression therapy.
Daniel A Galvão; Dennis R Taaffe; Nigel Spry; David Joseph; Robert U Newton
Related Documents :
9150497 - Training a large number of laboratory mice using running wheels and analyzing running b...
2022207 - Assessment of running velocity at maximal oxygen uptake.
17133867 - Triturus newts defy the running-swimming dilemma.
1223207 - Physiological parameters related to running performance in college trackmen.
12167677 - Mass-independent fractionation of oxygen isotopes during thermal decomposition of carbo...
3795097 - The diving response in man: effects on sympathetic activity in muscle and skin nerve fa...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-15
Journal Detail:
Title:  The Journal of urology     Volume:  -     ISSN:  1527-3792     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376374     Medline TA:  J Urol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Edith Cowan University Health and Wellness Institute, School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Dutasteride reduces prostatitis symptoms compared with placebo in men enrolled in the REDUCE study.
Next Document:  Intratumor C-Reactive Protein as a Biomarker of Prognosis in Localized Renal Cell Carcinoma.